New limits advised for anemia drugs.
Mitka
Mike
M
D000740:Anemia / Q000150:complications / Q000188:drug therapy*; D002908:Chronic Disease; D004921:Erythropoietin / Q000009:adverse effects* / Q000627:therapeutic use; D006397:Hematinics / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007674:Kidney Diseases / Q000150:complications; D007880:Legislation, Drug; D009369:Neoplasms / Q000150:complications; D011994:Recombinant Proteins; D014481:United States; D014486:United States Food and Drug Administration
D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin